Kohei Hasegawa1, Rachel W Linnemann, Jonathan M Mansbach, Nadim J Ajami, Janice A Espinola, Joseph F Petrosino, Pedro A Piedra, Michelle D Stevenson, Ashley F Sullivan, Amy D Thompson, Carlos A Camargo. 1. From the *Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; †Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia; ‡Department of Medicine, Boston Children's Hospital, Boston, Massachusetts; §Alkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas; ¶Department of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, Texas; ‖Department of Pediatrics, University of Louisville, Louisville, Kentucky; and **Alfred I. duPont Hospital for Children, Wilmington, Delaware.
Abstract
BACKGROUND: Little is known about the relationship of airway microbiota with bronchiolitis in infants. We aimed to identify nasal airway microbiota profiles and to determine their association with the likelihood of bronchiolitis in infants. METHODS: A case-control study was conducted. As a part of a multicenter prospective study, we collected nasal airway samples from 40 infants hospitalized with bronchiolitis. We concurrently enrolled 110 age-matched healthy controls. By applying 16S ribosomal RNA gene sequencing and an unbiased clustering approach to these 150 nasal samples, we identified microbiota profiles and determined the association of microbiota profiles with likelihood of bronchiolitis. RESULTS: Overall, the median age was 3 months and 56% were male. Unbiased clustering of airway microbiota identified 4 distinct profiles: Moraxella-dominant profile (37%), Corynebacterium/Dolosigranulum-dominant profile (27%), Staphylococcus-dominant profile (15%) and mixed profile (20%). Proportion of bronchiolitis was lowest in infants with Moraxella-dominant profile (14%) and highest in those with Staphylococcus-dominant profile (57%), corresponding to an odds ratio of 7.80 (95% confidence interval, 2.64-24.9; P < 0.001). In the multivariable model, the association between Staphylococcus-dominant profile and greater likelihood of bronchiolitis persisted (odds ratio for comparison with Moraxella-dominant profile, 5.16; 95% confidence interval, 1.26-22.9; P = 0.03). By contrast, Corynebacterium/Dolosigranulum-dominant profile group had low proportion of infants with bronchiolitis (17%); the likelihood of bronchiolitis in this group did not significantly differ from those with Moraxella-dominant profile in both unadjusted and adjusted analyses. CONCLUSIONS: In this case-control study, we identified 4 distinct nasal airway microbiota profiles in infants. Moraxella-dominant and Corynebacterium/Dolosigranulum-dominant profiles were associated with low likelihood of bronchiolitis, while Staphylococcus-dominant profile was associated with high likelihood of bronchiolitis.
BACKGROUND: Little is known about the relationship of airway microbiota with bronchiolitis in infants. We aimed to identify nasal airway microbiota profiles and to determine their association with the likelihood of bronchiolitis in infants. METHODS: A case-control study was conducted. As a part of a multicenter prospective study, we collected nasal airway samples from 40 infants hospitalized with bronchiolitis. We concurrently enrolled 110 age-matched healthy controls. By applying 16S ribosomal RNA gene sequencing and an unbiased clustering approach to these 150 nasal samples, we identified microbiota profiles and determined the association of microbiota profiles with likelihood of bronchiolitis. RESULTS: Overall, the median age was 3 months and 56% were male. Unbiased clustering of airway microbiota identified 4 distinct profiles: Moraxella-dominant profile (37%), Corynebacterium/Dolosigranulum-dominant profile (27%), Staphylococcus-dominant profile (15%) and mixed profile (20%). Proportion of bronchiolitis was lowest in infants with Moraxella-dominant profile (14%) and highest in those with Staphylococcus-dominant profile (57%), corresponding to an odds ratio of 7.80 (95% confidence interval, 2.64-24.9; P < 0.001). In the multivariable model, the association between Staphylococcus-dominant profile and greater likelihood of bronchiolitis persisted (odds ratio for comparison with Moraxella-dominant profile, 5.16; 95% confidence interval, 1.26-22.9; P = 0.03). By contrast, Corynebacterium/Dolosigranulum-dominant profile group had low proportion of infants with bronchiolitis (17%); the likelihood of bronchiolitis in this group did not significantly differ from those with Moraxella-dominant profile in both unadjusted and adjusted analyses. CONCLUSIONS: In this case-control study, we identified 4 distinct nasal airway microbiota profiles in infants. Moraxella-dominant and Corynebacterium/Dolosigranulum-dominant profiles were associated with low likelihood of bronchiolitis, while Staphylococcus-dominant profile was associated with high likelihood of bronchiolitis.
Authors: Shawn L Ralston; Allan S Lieberthal; H Cody Meissner; Brian K Alverson; Jill E Baley; Anne M Gadomski; David W Johnson; Michael J Light; Nizar F Maraqa; Eneida A Mendonca; Kieran J Phelan; Joseph J Zorc; Danette Stanko-Lopp; Mark A Brown; Ian Nathanson; Elizabeth Rosenblum; Stephen Sayles; Sinsi Hernandez-Cancio Journal: Pediatrics Date: 2014-11 Impact factor: 7.124
Authors: Giske Biesbroek; Evgeni Tsivtsivadze; Elisabeth A M Sanders; Roy Montijn; Reinier H Veenhoven; Bart J F Keijser; Debby Bogaert Journal: Am J Respir Crit Care Med Date: 2014-12-01 Impact factor: 21.405
Authors: Jeppe M Larsen; Hanieh S Musavian; Tariq M Butt; Camilla Ingvorsen; Anna H Thysen; Susanne Brix Journal: Immunology Date: 2015-02 Impact factor: 7.397
Authors: Jonathan M Mansbach; Kohei Hasegawa; David M Henke; Nadim J Ajami; Joseph F Petrosino; Chad A Shaw; Pedro A Piedra; Ashley F Sullivan; Janice A Espinola; Carlos A Camargo Journal: J Allergy Clin Immunol Date: 2016-04-06 Impact factor: 10.793
Authors: Katherine M Hunt; James A Foster; Larry J Forney; Ursel M E Schütte; Daniel L Beck; Zaid Abdo; Lawrence K Fox; Janet E Williams; Michelle K McGuire; Mark A McGuire Journal: PLoS One Date: 2011-06-17 Impact factor: 3.240
Authors: Shu Mei Teo; Danny Mok; Kym Pham; Merci Kusel; Michael Serralha; Niamh Troy; Barbara J Holt; Belinda J Hales; Michael L Walker; Elysia Hollams; Yury A Bochkov; Kristine Grindle; Sebastian L Johnston; James E Gern; Peter D Sly; Patrick G Holt; Kathryn E Holt; Michael Inouye Journal: Cell Host Microbe Date: 2015-04-09 Impact factor: 21.023
Authors: Pamela N Luna; Kohei Hasegawa; Nadim J Ajami; Janice A Espinola; David M Henke; Joseph F Petrosino; Pedro A Piedra; Ashley F Sullivan; Carlos A Camargo; Chad A Shaw; Jonathan M Mansbach Journal: Microbiome Date: 2018-01-03 Impact factor: 14.650
Authors: Thomas H A Ederveen; Gerben Ferwerda; Inge M Ahout; Marloes Vissers; Ronald de Groot; Jos Boekhorst; Harro M Timmerman; Martijn A Huynen; Sacha A F T van Hijum; Marien I de Jonge Journal: Microbiome Date: 2018-01-11 Impact factor: 14.650
Authors: Kohei Hasegawa; Christopher J Stewart; Jonathan M Mansbach; Rachel W Linnemann; Nadim J Ajami; Joseph F Petrosino; Carlos A Camargo Journal: BMC Res Notes Date: 2017-07-26
Authors: Markus J Lehtinen; Ashley A Hibberd; Sofia Männikkö; Nicolas Yeung; Tommi Kauko; Sofia Forssten; Liisa Lehtoranta; Sampo J Lahtinen; Buffy Stahl; Anna Lyra; Ronald B Turner Journal: Sci Rep Date: 2018-07-30 Impact factor: 4.379
Authors: Chin-Yi Chu; Xing Qiu; Matthew N McCall; Lu Wang; Anthony Corbett; Jeanne Holden-Wiltse; Christopher Slaunwhite; Alex Grier; Steven R Gill; Gloria S Pryhuber; Ann R Falsey; David J Topham; Mary T Caserta; Edward E Walsh; Thomas J Mariani Journal: J Infect Dis Date: 2021-05-20 Impact factor: 7.759